BofA raised the firm’s price target on Albemarle (ALB) to $225 from $190 and keeps a Buy rating on the shares. Commodity markets inflated rapidly through March and into April due to the Iran conflict, which is driving material upside to upstream forecasts for 2026 starting in Q2, while simultaneously resulting in cuts to downstream producers, the analyst tells investors in a preview for the U.S. chemicals group.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALB:
- Albemarle price target raised to $210 from $190 at Citi
- Albemarle, Onto, Qorvo, JPMorgan, Skyworks Trending With Analysts
- Albemarle Announces Upcoming Retirement of Chief Accounting Officer
- Morning Movers: Netflix falls after Q1 earnings, co-founder plan to leave board
- Albemarle downgraded to Neutral from Outperform at Baird